389 related articles for article (PubMed ID: 26110029)
21. Epigenetic signatures of familial cancer are characteristic of tumor type and family category.
Joensuu EI; Abdel-Rahman WM; Ollikainen M; Ruosaari S; Knuutila S; Peltomäki P
Cancer Res; 2008 Jun; 68(12):4597-605. PubMed ID: 18559504
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation markers in colorectal cancer.
Kim MS; Lee J; Sidransky D
Cancer Metastasis Rev; 2010 Mar; 29(1):181-206. PubMed ID: 20135198
[TBL] [Abstract][Full Text] [Related]
23. DNA methylation and microRNA biomarkers for noninvasive detection of gastric and colorectal cancer.
Toiyama Y; Okugawa Y; Goel A
Biochem Biophys Res Commun; 2014 Dec; 455(1-2):43-57. PubMed ID: 25128828
[TBL] [Abstract][Full Text] [Related]
24. Pattern of expression of genes linked to epigenetic silencing in human breast cancer.
Munot K; Bell SM; Lane S; Horgan K; Hanby AM; Speirs V
Hum Pathol; 2006 Aug; 37(8):989-99. PubMed ID: 16867861
[TBL] [Abstract][Full Text] [Related]
25. Molecular diagnostic applications of DNA methylation technology.
Cottrell SE
Clin Biochem; 2004 Jul; 37(7):595-604. PubMed ID: 15234241
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
27. [Epigenetic markers of esophageal cancer: DNA methylation].
Kit OI; Vodolazhskiy DI; Kolesnikov EN; Timoshkina NN
Biomed Khim; 2016 Jul; 62(5):520-526. PubMed ID: 27797326
[TBL] [Abstract][Full Text] [Related]
28. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas.
Virmani AK; Rathi A; Sathyanarayana UG; Padar A; Huang CX; Cunnigham HT; Farinas AJ; Milchgrub S; Euhus DM; Gilcrease M; Herman J; Minna JD; Gazdar AF
Clin Cancer Res; 2001 Jul; 7(7):1998-2004. PubMed ID: 11448917
[TBL] [Abstract][Full Text] [Related]
29. The value of epigenetic biomarkers in breast cancer.
Parrella P
Biomark Med; 2018 Sep; 12(9):937-940. PubMed ID: 30041537
[No Abstract] [Full Text] [Related]
30. Interplay between regulation by methylation and noncoding RNAs in cancers.
Lu CX; Wu XL; Zhang GY; Gu XT; Ma X; He DX
Eur J Cancer Prev; 2018 Jul; 27(4):418-424. PubMed ID: 29557800
[TBL] [Abstract][Full Text] [Related]
31. Methylation and gene silencing of the Ras-related GTPase gene in lung and breast cancers.
Suzuki M; Shigematsu H; Shames DS; Sunaga N; Takahashi T; Shivapurkar N; Iizasa T; Minna JD; Fujisawa T; Gazdar AF
Ann Surg Oncol; 2007 Apr; 14(4):1397-404. PubMed ID: 17195088
[TBL] [Abstract][Full Text] [Related]
32. Epigenetic diagnostics of cancer--the application of DNA methylation markers.
Paluszczak J; Baer-Dubowska W
J Appl Genet; 2006; 47(4):365-75. PubMed ID: 17132902
[TBL] [Abstract][Full Text] [Related]
33. Epigenetics in esophageal cancers.
Ahrens TD; Werner M; Lassmann S
Cell Tissue Res; 2014 Jun; 356(3):643-55. PubMed ID: 24816987
[TBL] [Abstract][Full Text] [Related]
34. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
35. A novel reannotation strategy for dissecting DNA methylation patterns of human long intergenic non-coding RNAs in cancers.
Zhi H; Ning S; Li X; Li Y; Wu W; Li X
Nucleic Acids Res; 2014 Jul; 42(13):8258-70. PubMed ID: 25013169
[TBL] [Abstract][Full Text] [Related]
36. Profiling DNA Methylation Patterns of Non-coding RNAs (ncRNAs) in Human Disease.
Zhi H; Li Y; Wang L
Adv Exp Med Biol; 2018; 1094():49-64. PubMed ID: 30191487
[TBL] [Abstract][Full Text] [Related]
37. Impaired expression and promotor hypermethylation of O6-methylguanine-DNA methyltransferase in retinoblastoma tissues.
Choy KW; Pang CP; To KF; Yu CB; Ng JS; Lam DS
Invest Ophthalmol Vis Sci; 2002 May; 43(5):1344-9. PubMed ID: 11980845
[TBL] [Abstract][Full Text] [Related]
38. Aberrant DNA methylation associated with aggressiveness of gastrointestinal stromal tumour.
Okamoto Y; Sawaki A; Ito S; Nishida T; Takahashi T; Toyota M; Suzuki H; Shinomura Y; Takeuchi I; Shinjo K; An B; Ito H; Yamao K; Fujii M; Murakami H; Osada H; Kataoka H; Joh T; Sekido Y; Kondo Y
Gut; 2012 Mar; 61(3):392-401. PubMed ID: 21708825
[TBL] [Abstract][Full Text] [Related]
39. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
